Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue (2022)
Attributed to:
MRC Centre for Reproductive Health at the University of Edinburgh
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/eci.13779
PubMed Identifier: 35342940
Publication URI: http://europepmc.org/abstract/MED/35342940
Type: Journal Article/Review
Parent Publication: European Journal of Clinical Investigation
Issue: 7
ISSN: 0014-2972